Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

And donating blood three times per year could possibly save you, according to researchers at the Francis Crick Institute in ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...

High body mass index affects outcomes in acute lymphoblastic leukemia (ALL), highlighting the need for targeted interventions ...

A new cancer treatment discovered by the University of California, San Diego Sanford Stem Cell Institute (SSCI) and developed ...

Gene therapy is revolutionizing how they're treated, and the Fred Hutch Cancer Center in Seattle is at the center of it all. ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of immature myeloid cells. Current treatments often fail to achieve durable remission, underscoring the ...

A local car dealership has sent warm wishes to Franciscan cancer patients.

The 54-year-old CEO of Sermo is running relentlessly in an effort to raise $1 million for stem cell transplant research.

Bubbly and full of zeal, the Pomona resident remains positive despite facing his second battle with the disease. He expressed ...